Published: November 17, 2011 at 4:04 pm

NetApp Inc (NTAP) shares sunk from $40.74 at close Wednesday to trade at just $35.57 a share as of 3:30pm EST. NTAP prices fell almost 13% “after the company said late Wednesday that for its fiscal third-quarter, it expects to earn between 36 cents and 40 cents a share, or between 56 cents and 60 cents a share, excluding certain items, on revenue in a range of $1.52 billion to $1.61 billion. That forecast fell short of the 63 cents a share on $1.65 billion in revenue estimated by analysts surveyed by FactSet Research,” reports MarketWatch.

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in NTAP since the end of June. We did not take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.